Latest cervical cancer Stories
BEDFORD, Mass., July 18, 2012 /PRNewswire/ -- Hologic, Inc. (Hologic or the Company) (Nasdaq: HOLX), a leading developer, manufacturer and supplier of premium diagnostics products, medical imaging systems and surgical products dedicated to serving the healthcare needs of women, announced today that the NVVP (Netherlands Society for Pathology) has approved the use of the Hologic Cervista HPV HR test for detecting human papillomavirus in the Dutch national cervical screening programme.[i]...
Monitoring the effectiveness of the HPV vaccine in Canada requires that data from multiple registries and other data sources be combined. Linking registries can be problematic, however, since they are often managed by unrelated organizations. Privacy legislation may also restrict the sharing of data for such linkages. To address these challenges, Dr. Khaled El-Emam and his team at the CHEO Research Institute have developed a secure protocol that allows the linking of individual patient...
Study shows evidence of herd protection The HPV vaccine not only has resulted in a decrease in human papillomavirus infection in immunized teens but also in teens who were not immunized. The study is believed to be the first to show a substantial decrease in HPV infection in a community setting as well as herd protection – a decrease in infection rates among unimmunized individuals that occurs when a critical mass of people in a community is immunized against a contagious disease....
NORTHFIELD, Ill., July 3, 2012 /PRNewswire-USNewswire/ -- The College of American Pathologists (CAP) and the American Society for Colposcopy and Cervical Pathology (ASCCP) jointly issued The Lower Anogenital Squamous Terminology (LAST) Standardization Project for HPV-Associated Lesions: Background and Consensus Recommendations. (Logo: http://photos.prnewswire.com/prnh/20120314/DC69899LOGO-a) The CAP/ASCCP LAST Project consensus recommendations were released on June 28, 2012, in the...
NAIROBI, Kenya, June 28, 2012 /PRNewswire/ -- A team of IBM (NYSE: IBM) experts today presented a plan to the Kenyan Ministry of Health and the United States Embassy in Kenya to encourage more women to request screening for cervical cancer, giving them a better chance at receiving life-saving treatment. (Logo: http://photos.prnewswire.com/prnh/20090416/IBMLOGO )Currently, only three-percent of women between the ages of 15-49 request cervical cancer screening. Given that...
By Ashley Strauss, Ivanhoe Health Correspondent (Ivanhoe Newswire) – 60% of all oral cancers and 90% of all cervical cancers are directly linked to HPV. Now, doctors are saying men should be paying attention to the ads as much as women. HPV is also responsible for 90% of anal cancers and 50 % penile cancers. HPV is a virus contracted through sexual contact, and can lead to genital warts, as well as lesions, cancers, and even death. The vaccine Gardasil helps to prevent the virus,...
Research published today in the Journal of the Royal Society of Medicine raises further questions about a trial of HPV vaccines in India. The trial, which has now been halted and is the subject of an investigation by the Indian government, was examining the safety and feasibility of offering a vaccine against the virus associated with cervical cancer. The new study by researchers at Queen Mary, University of London and the University of Edinburgh suggests that lack of data on cervical...
Singapore, June 12, 2012 - (ACN Newswire) - A team of scientists from A*STAR's Institute of Medical Biology (IMB) and Genome Institute of Singapore (GIS) together with clinicians from Boston's Brigham and Women's Hospital (BWH) have identified a unique set of cells in the cervix that are the cause of human papillomaviruses (HPV) related cervical cancers. Significantly, the team also showed that these cells do not regenerate when excised. These findings have immense clinical implications in...
Researchers from Brigham and Women's Hospital uncover a population of cells that are targeted by the cancer-causing human papillomaviruses Virtually all cervical cancers are caused by HPV infections, with just two HPV types, 16 and 18, responsible for about 70 percent of all cases, according to the National Cancer Institute. Scientists have presumed for decades that the cervical cancers that develop from HPV infection arise in a specific location in the cervix. Now, new research from...
Researchers at Moffitt Cancer Center have developed and tested in mice a synthetic vaccine and found it effective in killing human papillomavirus-derived cancer, a virus linked to cervical cancers among others. The research was published in a recent issue of Cancer Immunology, Immunotherapy. "Vaccines for cancer can be good alternatives to conventional therapies that result in serious side-effects and are rarely effective against advanced disease," said Esteban Celis, M.D., Ph.D., senior...
Latest cervical cancer Reference Libraries
The Colposcopy is a preventive procedure to identify a possible abnormal cells or tissue on the cervix, vagina and vulva. By illuminating and magnifying the area with a coloscope during the examination, areas of concern can be identified earlier by the colposcopist. The procedure was developed by a German physician Hans Hinselmann in 1925 with the help of Dr. Helmut Wirths. Cause for the Procedure This examination has multiple candidates. If a patient has been a victim of a sexual...
The Colposcopy is a preventive procedure to identify a possible abnormal cells or tissue on the cervix, vagina and vulva. By illuminating and magnifying the area with a coloscope during the examination, areas of concern can be identified earlier by the colposcopist. The procedure was developed by a German physician Hans Hinselmann in 1925 with the help of Dr. Helmut Wirths. Cause for the Procedure This examination has multiple candidates. If a patient has been a victim of a sexual assault...
A human papillomavirus (HPV), a member of the papillomavirus family, is capable of infecting humans. HPVs establish productive infections in the skin or mucous membranes. Most of the 200 known types cause no symptoms in most people. Some types can cause warts, while others can lead to cancer. There are more than 30 to 40 types of HPV that are typically transmitted through sexual contact and infect the anogenital region. High risk HPV, can lead to cancer, in fact HPV infection is a cause of...
